𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Gemcitabine and docetaxel as first-line treatment for advanced urothelial carcinoma: a phase II study

✍ Scribed by Ardavanis, A; Tryfonopoulos, D; Alexopoulos, A; Kandylis, C; Lainakis, G; Rigatos, G

Book ID
109998397
Publisher
Nature Publishing Group
Year
2005
Tongue
English
Weight
97 KB
Volume
92
Category
Article
ISSN
0007-0920

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A phase II study of gemcitabine and doce
A phase II study of gemcitabine and docetaxel therapy in patients with advanced urothelial carcinoma
✍ Barbara J. Gitlitz; Carole Baker; Yvonne Chapman; Heather J. Allen; Linda D. Bos πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 79 KB πŸ‘ 2 views

## Abstract ## BACKGROUND The objectives of the current study were to evaluate the safety and efficacy of gemcitabine plus docetaxel in patients with unresectable (Stage T4 or β‰₯ N1) metastatic or locally advanced transitional cell carcinoma (TCC) of the urothelial tract. ## METHODS A total of 27

The combination of gemcitabine and carbo
The combination of gemcitabine and carboplatin as first-line treatment in patients with advanced urothelial carcinoma : A Phase II study of the Hellenic Cooperative Oncology Group
✍ Aristotle Bamias; Lia A. Moulopoulos; Aggelos Koutras; Gerassimos Aravantinos; G πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 132 KB

## Abstract ## BACKGROUND The toxicity of platinum‐based combinations represents a common problem for patients with advanced urothelial carcinoma. The authors previously reported encouraging efficacy for the combination of carboplatin and gemcitabine in patients considered to be unfit for cisplati